Catalyst Wire Dossier Catalyst Wire Dossier

Expanded NK cell immunotherapy

expanded natural killer (NK) cells · New Approaches to Neuroblastoma Therapy Consortium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Expanded NK cell immunotherapy, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells [Phase 1]

See pricing